National Heart, Lung, Blood Institute (NHLBI) will provide a Summary Statement
National Institutes of Health (NIH)
the United State's medical research agency, a federal government agency composed of diverse Institutes and Centers
that conduct and support biomedical and behavioral research. NIH Homepage
Institute that provides leadership for a national program in diseases of the heart, lung, and blood as well as blood resources, sleep disorders and the Woman's Health Initiative. NHLBI Homepage
Summary Statement for each application,
whether discussed or not at the peer review meeting.
official document with a short synopsis of peer reviewer critiques scores, codes indicating various concerns (e.g., human subjects research), and a recommended budget.
Summary Statements include:
- Resume and summary of the main points discussed during the review meeting and major strengths and weaknesses
- Reviewer critiques containing more information about the strengths and weaknesses detected by peer reviewers
- Codes and budget information
- Meeting Roster
- Contact information for the Program Official (PO)
Program Official (PO) to whom
staff member who oversees a scientific program and the progress of grants and contracts in a portfolio. This title is most frequently used to refer to the scientific or technical representative for grants, but the generic "program official" term also may refer to a Project Officer
the NIH staff member designated as a Contracting Officer's Technical Representative (COTR) to coordinate the substantive aspects of an acquisition from its development through to contract award and administration. Also known as Contracting Officer's Technical Representative ( COTR ).
if the funding mechanism is a contract. Also known as Health Scientist Administrators or Program Director.
Grant is assigned
financial assistance mechanism providing money, property, or both to an eligible entity to carry out an approved project or activity. A grant is used whenever the NIH Institute or Center anticipates no substantial programmatic involvement with the recipient during performance of the financially assisted activities.
Within approximately 30 days, your summary statement will
be available via your NIH Commons account. You can
find general information about pay lines in NHLBI’s
General Funding Guidelines.
If human subjects
Human Subject concerns arise during peer review, your summary
statement will include code 44, which bars funding until you
address all concerns. This may occur as a result of an
absent or inadequate monitoring plan or concerns about risks
versus benefits for subjects. Your Program Official(PO) will
contact you to discuss how to resolve the issues raised in
the summary statement. These concerns will need to be
resolved before NHLBAC
Legally defined term for living persons about whom an investigator obtains specimens or data through direct interaction
any communication or other interpersonal contact between an investigator and a human subject. For more information, go to definitions in 45 CFR 46.102
and full 45 CFR 46
or intervention or through identifiable, private information. Regulations include but are not limited to human organs, tissues, body fluids, and recorded information. Term is defined differently by FDA.
National Heart, Lung, and Blood Advisory Council (NHLBAC) review. The NOA
an independent group commonly called Council that considers applications and advises the institute and recommends funding for applications that show promise of making valuable contributions. NHLBAC Homepage
Notice of Award (NOA) cannot be issued
until this is done.
a legally binding document, notifying the grantee and others that an award has been made, including all terms and conditions of the award and outlining the obligation of Federal funds. Previously known as Notice of Grant Award(NGA).
Page Last Updated: February 2011
Content Manager: ClinicalResearchPolicyManager@nhlbi.nih.gov